Researchers are excited about the medication , a novel dual agonist showing significant outcomes in initial trials for body reduction . It acts by targeting both hormones : GLP-1 and GIP, which , when https://adrianalnqa488410.dailyblogzz.com/41254141/the-new-hope-for-size-reduction